Expanding Aesthetic Portfolio The recent acquisition of Eclipse Medical’s aesthetics-focused assets significantly broadens Crown Aesthetics’ product offerings, creating opportunities to cross-sell innovative skincare and medical devices to existing clients and attract new practitioners interested in advanced aesthetic treatments.

New Product Launches The launch of FDA-approved devices like SkinPen Precision Elite and BIOJUVE demonstrates Crown’s focus on innovative, science-based products, opening sales opportunities with clinics, dermatologists, and medical spa chains seeking cutting-edge aesthetic solutions.

Strategic Partnerships Crown’s recent collaborations, such as with digital health platform GetHarley in the UK & Ireland, suggest potential channels for targeted marketing and distribution partnerships, expanding reach into digital health segments and tele-aesthetic services.

Focused Market Growth With plans to strengthen its presence in the UK and Ireland and appointing dedicated marketing managers, there are enhanced opportunities to engage with regional clinics and aesthetic practices eager to adopt new, regulatory-approved skincare devices.

Customer Recognition Receiving the 2024 Excellence in Customer Service Award underscores Crown’s commitment to client satisfaction, which can be leveraged to build long-term relationships and encourage repeat business among high-value aesthetic providers.